Publications

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Treatment of chronic or relapsing COVID-19 in immunodeficiency.

Brown, L-AK; Moran, E; Goodman, A; Baxendale, H; Bermingham, W; Buckland, M; AbdulKhaliq, I; Jarvis, H; Hunter, M; Karanam, S; Patel, A; Jenkins, M; Robbins, A; Khan, S; Simpson, T; Jolles, S; Underwood, J; Savic, S; Richter, A; Shields, A; Brown, M; Lowe, DM;

2021

The Journal of allergy and clinical immunology, (2021).149 2 10.1016/j.jaci.2021.10.031.

On the role of statisticians and modelers in responding to AIDS and COVID-19.

Jewell, BL; JEWELL, NP;

2021

Statistics in medicine, (2021).40 11 10.1002/sim.8943.

Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa.

KASEJE, N; Oruenjo, K; Kaseje, D; Evans, TG; Tanner, M; HAINES, A; Nyikal, J;

2021

BMJ global health, (2021).6 5 10.1136/bmjgh-2021-006289.

Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.

Read, JM; Green, CA; Harrison, EM; Docherty, AB; FUNK, S; Harrison, J; Girvan, M; Hardwick, HE; Turtle, L; Dunning, J; Nguyen-Van-Tam, JS; Openshaw, PJ; Baillie, JK; Semple, MG; ISARIC4C investigators,;

2021

Lancet, (2021).398 10305 10.1016/S0140-6736(21)01786-4.

Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.

Butt, AA; Nafady-Hego, H; CHEMAITELLY, H; Abou-Samra, A-B; Khal, AA; Coyle, PV; Kanaani, ZA; Kaleeckal, AH; Latif, AN; Masalmani, YA; Bertollini, R; Raddad, LJ A;

2021

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2021).110, 10.1016/j.ijid.2021.08.008.

Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine.

World Health Organisation SAGE Working Group on CO,;

2021

Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine (2021).

Time to evaluate COVID-19 contact-tracing apps.

Colizza, V; Grill, E; Mikolajczyk, R; Cattuto, C; KUCHARSKI, A; Riley, S; Kendall, M; Lythgoe, K; Bonsall, D; Wymant, C; Abeler-Dörner, L; Ferretti, L; Fraser, C;

2021

Nature medicine, (2021).27 3 10.1038/s41591-021-01236-6.

SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks.

Abu-Raddad, L; CHEMAITELLY, H; Coyle, P; Malek, J; Ahmed, A; Mohamoud, Y; Younuskunju, S; Ayoub, H; Kanaani, ZA; Kuwari, EA; Butt, A; Jeremijenko, A; Kaleeckal, AH; Latif, AN; Shaik, RM; Rahim, HA; Nasrallah, G; Yassine, H; Al Kuwari, M; Romaihi, HE A; Al-Thani, M; Khal, AA; Bertollini, R;

2021

medRxiv (2021). 10.1101/2021.01.15.21249731.

Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study.

OpenSAFELY Collaborative,; WONG, AY S; TOMLINSON, LA; Brown, JP; Elson, W; Walker, AJ; SCHULTZE, A; Morton, CE; Evans, D; Inglesby, P; MacKenna, B; BHASKARAN, K; RENTSCH, CT; POWELL, E; WILLIAMSON, E; Croker, R; Bacon, S; Hulme, W; Bates, C; Curtis, HJ; Mehrkar, A; Cockburn, J; MCDONALD, HI; MATHUR, R; WING, K; ... DOUGLAS, IJ.

2021

Journal of hematology & oncology, (2021).14 1 10.1186/s13045-021-01185-0.

Predicted norovirus resurgence in 2021-2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study.

O'REILLY, KM; Sandman, F; ALLEN, D; JARVIS, CI; Gimma, A; Douglas, A; Larkin, L; WONG, KL M; BAGUELIN, M; Baric, RS; Lindesmith, LC; Goldstein, RA; Breuer, J; EDMUNDS, WJ;

2021

BMC medicine, (2021).19 1 10.1186/s12916-021-02153-8.